CU23759A3 - Composiciones inmunogénicas - Google Patents
Composiciones inmunogénicasInfo
- Publication number
- CU23759A3 CU23759A3 CU20080216A CU20080216A CU23759A3 CU 23759 A3 CU23759 A3 CU 23759A3 CU 20080216 A CU20080216 A CU 20080216A CU 20080216 A CU20080216 A CU 20080216A CU 23759 A3 CU23759 A3 CU 23759A3
- Authority
- CU
- Cuba
- Prior art keywords
- composition
- antigen
- immune response
- immunogenic compositions
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención está relacionada con una composición inmunogénica para levantar una respuesta inmune frente a un antígeno, la composición que comprende el antígeno y la entidad de direccionamiento específica para células dendríticas residentes en la linfa. El uso de la composición inmunogénica en una vacuna y los métodos para potenciar la respuesta inmune utilizando la composición también se proporcionan. En contraste, la invención está relacionada con una composición inmunogénica para levantar una respuesta inmune frente a un antígeno, donde la composición comprende el antígeno y una entidad de direccionamiento específica para células dendríticas derivadas de tejido y una vacuna que comprende dicha composición.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80199806P | 2006-05-19 | 2006-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23759A3 true CU23759A3 (es) | 2012-01-31 |
Family
ID=38722861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20080216A CU23759A3 (es) | 2006-05-19 | 2008-11-19 | Composiciones inmunogénicas |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090304735A1 (es) |
EP (1) | EP2018182A4 (es) |
CN (1) | CN101489589A (es) |
AU (1) | AU2007252296A1 (es) |
CA (1) | CA2652426A1 (es) |
CU (1) | CU23759A3 (es) |
NZ (1) | NZ572808A (es) |
WO (1) | WO2007134385A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8062852B2 (en) * | 2007-10-01 | 2011-11-22 | The Children's Hospital And Regional Medical Center | Detection and treatment of autoimmune disorders |
CN103068837B (zh) | 2010-05-28 | 2015-06-24 | 斯匹遐生物技术公司 | 嵌合momp抗原、方法和使用 |
US20130302369A1 (en) * | 2011-02-04 | 2013-11-14 | Omar Yousif Abdelmagid | Immunogenic Bordetella Bronchiseptica Compositions |
ES2565198T3 (es) * | 2011-04-12 | 2016-04-01 | Intervet International B.V. | Metapneumovirus aviar en oncólisis |
CN103748221A (zh) * | 2011-08-04 | 2014-04-23 | 独立行政法人产业技术综合研究所 | 由蛋白g细胞膜外结构域突变体的串联型多聚体组成的新型改性蛋白 |
EP2985288B1 (en) | 2013-05-31 | 2019-11-13 | Pulike Biological Engineering, Inc. | Porcine pseudorabies virus, vaccine composition and preparation method and use thereof |
CN103923884B (zh) * | 2014-02-21 | 2017-03-29 | 普莱柯生物工程股份有限公司 | 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
CN104250640A (zh) | 2014-08-22 | 2014-12-31 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
BR112018008090A2 (pt) * | 2015-10-22 | 2018-11-13 | Modernatx Inc | vacina de vírus do herpes simplex. |
GB201605210D0 (en) | 2016-03-29 | 2016-05-11 | Oxford Immunotec Ltd | Assay |
CN106047902B (zh) * | 2016-05-26 | 2020-05-08 | 河北农业大学 | 一种基因gBabc |
CN109414023A (zh) * | 2016-06-29 | 2019-03-01 | 杜克大学 | 用嵌合脊髓灰质炎病毒激活抗原呈递细胞的组合物和方法 |
CN108276476B (zh) * | 2017-12-27 | 2019-11-22 | 东北农业大学 | 一种鸡骨髓源树突状细胞靶向肽sp及其用途 |
JP7132339B2 (ja) * | 2018-02-01 | 2022-09-06 | シァメン・ユニヴァーシティ | 腫瘍を治療するための仮性狂犬病ウイルス |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093524A2 (en) * | 2004-07-16 | 2006-09-08 | The General Hospital Corporation | Antigen-carbohydrate conjugates |
-
2007
- 2007-05-18 CN CNA200780026608XA patent/CN101489589A/zh active Pending
- 2007-05-18 US US12/227,515 patent/US20090304735A1/en not_active Abandoned
- 2007-05-18 NZ NZ572808A patent/NZ572808A/en not_active IP Right Cessation
- 2007-05-18 EP EP07718937A patent/EP2018182A4/en not_active Withdrawn
- 2007-05-18 WO PCT/AU2007/000691 patent/WO2007134385A1/en active Application Filing
- 2007-05-18 CA CA002652426A patent/CA2652426A1/en not_active Abandoned
- 2007-05-18 AU AU2007252296A patent/AU2007252296A1/en not_active Abandoned
-
2008
- 2008-11-19 CU CU20080216A patent/CU23759A3/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2018182A1 (en) | 2009-01-28 |
EP2018182A4 (en) | 2010-10-06 |
AU2007252296A1 (en) | 2007-11-29 |
CA2652426A1 (en) | 2007-11-29 |
CN101489589A (zh) | 2009-07-22 |
NZ572808A (en) | 2011-11-25 |
US20090304735A1 (en) | 2009-12-10 |
WO2007134385A1 (en) | 2007-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU23759A3 (es) | Composiciones inmunogénicas | |
MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
CO6751287A2 (es) | Composición antigénetica de micobacteria | |
CL2006000880A1 (es) | Composicion inmunogena para causar una respuesta inmunologica contra una especie helicobacter y circovirus porcino que comprende antigenos de dichos patogenos; metodo para inducir una respuesta inmunologica contra dichos patogenos; kit para preparar la composicion inmunogena. | |
CO6382137A2 (es) | Oligonucleótidos inmunoestimuladores | |
AR052498A1 (es) | Vacuna | |
DK1898948T3 (da) | Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans | |
CR20160206A (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5 | |
BRPI0708344B8 (pt) | vetores adenovirais quiméricos e composição imunogênica | |
CR20120310A (es) | Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico | |
BRPI1013780A2 (pt) | composições para imunização contra staphylococcus aureus. | |
ECSP10010438A (es) | ANTICUERPOS ANTI-CD79b E INMUNOCONJUGADOS Y METODOS DE USO | |
MY143347A (en) | Mucosal immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
UY31942A (es) | Formulaciones de adyuvante comprendiendo combinaciones de triterpenoides, esteroles, inmunomoduladores, polímeros y estimuladores de th2, procedimientos de preparación, composiciones y aplicaciones. | |
MX2013001527A (es) | Nuevas vacunas adyuvantes en base a adyuvantes de orientacion para anticuerpos directamente hacia celulas presentadoras de antigenos. | |
MX2007002787A (es) | Adyuvante de glicosilceramida para antigenos de sacarido. | |
BRPI0511026C1 (pt) | uso de um los neisserial, e, composição | |
BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
CU20120080A7 (es) | Formulaciones de anticuerpo | |
CO6511229A2 (es) | Metodos para reducir la actividad viricida en composiciones pcv-2 y composiciones pcv-2 con una inmunogeicidad mejorada | |
CL2011000382A1 (es) | Uso de una composicion inmunogenica que comprende una cantidad eficaz de un virus de sindrome disgenesico y respiratorio porcino (prrs) tipo ii para disminuir la incidencia, gravedad o prevenir los efectos de una enfermedad con fiebre alta de prrs. | |
CL2015001111A1 (es) | Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna. | |
TR201802380T4 (tr) | Benzonaftiridin içeren aşılar. | |
CL2011000914A1 (es) | Vacuna combinada estable completamente liquida que comprende antigenos difterico, tetanico, pertusico acelular, de haemophilus influenzae, y de virus de poliomielitis en donde el antigeno se haemophilus influenzae no esta sustancialmente absorbido sobre ningun adyuvante; y proceso de fabricacion. | |
AR059851A1 (es) | Anticuerpos de la egfl7 y metodos de uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent |